agilon health Inc (AGL) Stock Forecast & Price Target
agilon health Inc · NYSE
$98.69+0.69 (+0.70%)
15-min delayed · Jul 27, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 11 firms covering agilon health Inc, 4 rate it Buy or better, 6 sit at Hold, and 1 rate it Sell or worse, a hold consensus. The target range is very wide, $1.40 to $141.00 (about 100.7x), which points to deep disagreement over how to value the company rather than near-term timing. The average target of $58.04 sits 41% below the current $98.69. The rating mix has stayed broadly stable, with Buy-side ratings edging up from 2 to 4 over recent months. On the fundamentals, the Street sees revenue growth near -4% this year and 6% next, consensus EPS building from about $-1.42 next quarter toward $-0.62 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS11 ratings
Hold
Strong Buy00%
Buy436%
Hold655%
Sell19%
Strong Sell00%
Based on 11 analysts giving stock ratings to agilon health Inc.
As of Jul, 4 of 11 firms rate AGL a Buy (6 Hold, 1 Sell), the standing distribution of every covering firm's most recent active call.
AGL EPS & revenue forecast
EPS · NEXT QUARTER
$-1.42
Range $-2.05 – $-0.54 · 12 analysts · -79% YoY
Next period, 12 analysts expect agilon health Inc to earn $-1.42 a share (range $-2.05 – $-0.54), versus $-6.75 a year earlier. Full-year consensus is $-2.88, growing to $-0.62 the year after.
REVENUE · NEXT QUARTER
$1.4B
Range $1.3B – $1.5B · 12 analysts · -2% YoY
Revenue is expected to reach $1.4B (range $1.3B – $1.5B), -2.0% year-over-year. Full-year consensus is $5.7B, rising to $6.1B next year.
Top analysts covering agilon health Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on AGL.
#1
BS
Bill Sutherland
Benchmark · Rank #52
Buy
$95.00-3.7% to target
Overall win rate
44%
+ Follow
#2
Constantine Davides
JMP Securities · Rank #225
Hold
No targeton AGL
Overall win rate
34%
+ Follow
#3
Stephen Baxter
Wells Fargo
Buy
$141.00+42.9% to target
Coverage
—
+ Follow
#4
Andrew Mok
Barclays
Hold
$81.00-17.9% to target
Coverage
—
+ Follow
#5
Daniel Grosslight
Citigroup
Hold
$80.00-18.9% to target
Coverage
—
+ Follow
AGL stock forecast FAQ
What is AGL's average 12-month price target?+
The 11 analysts with a live target average $58.04 for agilon health Inc over the next 12 months, ranging from a $141.00 high to a $1.40 low.
Is AGL stock a Buy, Sell or Hold right now?+
The current consensus is Hold. Of the 11 analyst ratings, 4 are Buy or Strong Buy, 6 are Hold, and 1 are Sell or Strong Sell.
What are the highest and lowest price targets for AGL?+
The Street-high target is $141.00 (Wells Fargo), and the Street-low is $1.40 (Bernstein). The average of all 11 active targets is $58.04.
How many Wall Street analysts cover AGL?+
11 analysts have an active rating on agilon health Inc, and 11 firms carry a live 12-month price target.
Who is the most accurate analyst covering AGL?+
Among analysts who currently cover AGL, Bill Sutherland of Benchmark has the strongest overall Quantellect track record (Rank #52). Their current call is Buy with a $95.00 target.
What is agilon health Inc's projected EPS for next quarter?+
The consensus estimate is $-1.42 per share (range $-2.05 – $-0.54) across 12 analysts. Full-year EPS is projected at $-2.88, rising to $-0.62 the following year.
How much revenue is agilon health Inc expected to report next quarter?+
Consensus revenue is $1.4B (range $1.3B – $1.5B). Full-year revenue is projected at $5.7B, growing to $6.1B next year.
Have analysts been upgrading or downgrading AGL lately?+
As of Jul, 4 of 11 firms rate AGL a Buy (6 Hold, 1 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their AGL calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
